Leptin in relation to carcinoma In situ of the breast: A study of pre‐menopausal cases and controls

Leptin reflects the amount of energy stores, regulates energy balance and is associated with circulating levels of reproductive hormones and insulin‐like growth factor‐I (IGF‐I). Breast cancer has also been associated with obesity, reproductive hormones and circulating IGF‐I levels. To determine whether leptin is involved in the etiology of breast cancer, we compared serum leptin levels in 83 cases of pre‐menopausal carcinoma in situ of the breast and 69 healthy controls recruited in Massachusetts. Serum leptin levels were 13.69 + 1.3 ng/ml in cases and 16.03 + 1.7 ng/ml in controls. Data were also analyzed using multiple logistic regression with adjustment for known risk factors for the development of breast cancer as well as anthropometric, demographic and hormonal variables, including estradiol, prolactin, IGF‐I and IGF‐binding protein‐3. Odds ratios were 1.75 (95% CI, 0.73–4.21) for the second control‐defined tertile and 1.54 (0.46–5.16 ) for the third control‐defined tertile relative to the first. Thus, leptin does not appear to increase the risk of pre‐menopausal breast cancer in situ substantially. Int. J. Cancer 80:523–526, 1999. © 1999 Wiley‐Liss, Inc.

[1]  C. Mantzoros,et al.  Leptin: in search of role(s) in human physiology and pathophysiology , 1998, Clinical endocrinology.

[2]  C. Mantzoros,et al.  Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. , 1998, Epidemiology.

[3]  C. Mantzoros,et al.  Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. , 1998, Journal of the National Cancer Institute.

[4]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[5]  C. Mantzoros,et al.  Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men. , 1998, Obesity research.

[6]  Johannes D. Veldhuis,et al.  Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Mantzoros,et al.  Leptin: its role in obesity and beyond , 1997, Diabetologia.

[8]  G. Paolisso,et al.  Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. , 1997, The Journal of clinical endocrinology and metabolism.

[9]  C. Mantzoros,et al.  Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. , 1997, The Journal of clinical endocrinology and metabolism.

[10]  C. Mantzoros,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Leptin Concentrations in the Polycystic Ovary Syndrome* , 2022 .

[11]  R. Sen Aris,et al.  Regulation of in VivoGrowth Hormone Secretion by Leptin. , 1997, Endocrinology.

[12]  C. Mantzoros,et al.  A Longitudinal Assessment of Hormonal and Physical Alterations during Normal Puberty in Boys. v. Rising Leptin Levels May Signal the Onset of Puberty* , 2022 .

[13]  C. Mantzoros,et al.  Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. , 1997, British Journal of Cancer.

[14]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[15]  Hongping,et al.  Leptin is a metabolic signal to the reproductive system. , 1996, Endocrinology.

[16]  S. Klein,et al.  Radioimmunoassay of leptin in human plasma. , 1996, Clinical chemistry.

[17]  F. Chehab,et al.  Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin , 1996, Nature Genetics.

[18]  P. Lønning,et al.  Insulin-like growth factors in breast cancer. , 1996, Acta oncologica.

[19]  T. C. Linders,et al.  Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer , 1995, International journal of cancer.

[20]  R. Rosenfeld,et al.  Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. , 1993, The Journal of biological chemistry.

[21]  J. Bonneterre,et al.  Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. , 1993, European journal of cancer.